Southern Asia: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Southern Asia

The South Asian prophylactic medicaments containing insulin market totaled $X in 2022, surging by X% against the previous year. Overall, consumption continues to indicate resilient growth. The level of consumption peaked at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Southern Asia

In value terms, prophylactic medicaments containing insulin production rose slightly to $X in 2022 estimated in export price. In general, production posted resilient growth. The growth pace was the most rapid in 2019 with an increase of X% against the previous year. The level of production peaked at $X in 2020; however, from 2021 to 2022, production stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in Southern Asia

In 2022, overseas shipments of medicaments containing insulin but not antibiotics in measured doses were finally on the rise to reach X tons for the first time since 2013, thus ending a eight-year declining trend. Overall, exports, however, saw a deep reduction. The pace of growth appeared the most rapid in 2013 with an increase of X%. As a result, the exports reached the peak of X tons. From 2014 to 2022, the growth of the exports remained at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports surged to $X in 2022. In general, exports, however, recorded a mild downturn. The most prominent rate of growth was recorded in 2013 when exports increased by X%. As a result, the exports reached the peak of $X. From 2014 to 2022, the growth of the exports remained at a lower figure.

Exports by Country

The shipments of the one major exporters of medicaments containing insulin but not antibiotics in measured doses, namely India, represented more than two-thirds of total export.

India was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics in measured doses exports, with a CAGR of X% from 2012 to 2022. The shares of the largest exporters remained relatively stable throughout the analyzed period.

In value terms, India ($X) also remains the largest prophylactic medicaments containing insulin supplier in Southern Asia.

From 2012 to 2022, the average annual growth rate of value in India totaled X%.

Export Prices by Country

The export price in Southern Asia stood at $X per ton in 2022, with a decrease of X% against the previous year. Over the period under review, the export price, however, showed a buoyant expansion. The pace of growth was the most pronounced in 2019 when the export price increased by X% against the previous year. Over the period under review, the export prices reached the peak figure at $X per ton in 2020; however, from 2021 to 2022, the export prices failed to regain momentum.

As there is only one major export destination, the average price level is determined by prices for India.

From 2012 to 2022, the rate of growth in terms of prices for India amounted to X% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in Southern Asia

In 2022, supplies from abroad of medicaments containing insulin but not antibiotics in measured doses decreased by X% to X tons, falling for the second consecutive year after four years of growth. Overall, imports, however, saw perceptible growth. The growth pace was the most rapid in 2020 with an increase of X%. As a result, imports attained the peak of X tons. From 2021 to 2022, the growth of imports remained at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin imports reduced modestly to $X in 2022. Total imports indicated strong growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth appeared the most rapid in 2014 when imports increased by X%. Over the period under review, imports reached the maximum at $X in 2021, and then declined slightly in the following year.

Imports by Country

In 2022, Pakistan (X tons) was the major importer of medicaments containing insulin but not antibiotics in measured doses, committing X% of total imports. It was distantly followed by India (X tons), Bangladesh (X tons) and Nepal (X tons), together creating a X% share of total imports. Sri Lanka (X tons) followed a long way behind the leaders.

From 2012 to 2022, average annual rates of growth with regard to prophylactic medicaments containing insulin imports into Pakistan stood at X%. At the same time, India (X%) and Nepal (X%) displayed positive paces of growth. Moreover, India emerged as the fastest-growing importer imported in Southern Asia, with a CAGR of X% from 2012-2022. By contrast, Bangladesh (X%) and Sri Lanka (X%) illustrated a downward trend over the same period. From 2012 to 2022, the share of India and Nepal increased by X and X percentage points, respectively.

In value terms, India ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in measured doses in Southern Asia, comprising X% of total imports. The second position in the ranking was taken by Pakistan ($X), with a X% share of total imports. It was followed by Bangladesh, with a X% share.

In India, prophylactic medicaments containing insulin imports increased at an average annual rate of X% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Pakistan (X% per year) and Bangladesh (X% per year).

Import Prices by Country

In 2022, the import price in Southern Asia amounted to $X per ton, rising by X% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of X%. The most prominent rate of growth was recorded in 2021 when the import price increased by X% against the previous year. Over the period under review, import prices hit record highs in 2022 and is likely to see steady growth in the near future.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was India ($X per ton), while Pakistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Pakistan (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :